Clinical studies recruiting near Albury

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Creating A Risk Assessment Tool for Thunderstorm Asthma: the CARISTA Study
NA · Albury-Wodonga Health · University of Melbourne · NCT07055542 Phase II Randomised Controlled Trial of Patient-specific Adaptive vs. Continuous Abiraterone or eNZalutamide in mCRPC
Phase 2 · Border Medical Oncology Research Unit / The Border Cancer Ho · Leiden University Medical Center · NCT05393791 A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Phase 2 · Site AU61014 · Astellas Pharma Global Development, Inc. · NCT02960022 A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01
Phase 2 · Eye Clinic Albury Wodonga · Vantage Biosciences Ltd · NCT06770933 A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in
Phase 3 · Border Medical Oncology Research Unit · Nordic Lymphoma Group · NCT04332822 Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macul
Phase 3 · Eye Clinic Albury Wodonga · 4D Molecular Therapeutics · NCT07064759 Tiragolumab and Atezolizumab in Advanced Pan-cancer Patients
Phase 2 · Border Medical Oncology Research Unit · Omico · NCT06003621 A Phase I Study of BAY3498264 Given Together With Sotorasib in Participants Who Have Advanced Solid Cancers With Specifi
Phase 1 · Border Medical oncology - Albury Wodonga Regional Cancer Cen · Bayer · NCT06659341 Extension Study for the Port Delivery System With Ranibizumab (Portal)
Phase 3 · Eyeclinic Albury Wodonga · Hoffmann-La Roche · NCT03683251 Trial of INI-4001 in Patients With Advanced Solid Tumours
Phase 1 · The Border Cancer Hospital · Inimmune Corporation · NCT06302426 Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Pa
Phase 1/Phase 2 · Border Medical Oncology · Aptose Biosciences Inc. · NCT03850574 Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Phase 1 · Exelixis Clinical Site #116 · Exelixis · NCT05176483 A Trial of Palliative Chemotherapy, Radiation and Immune Treatment for Oesophageal Cancer: PALEO Study
Phase 2 · Border Medical Oncology · Australasian Gastro-Intestinal Trials Group · NCT06290505 A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Phase 2/Phase 3 · Eye Clinic Albury Wodonga (Site 425) · EyeBiotech Ltd. · NCT07440225 A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secon
Phase 2 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT07441642 A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult
Phase 3 · Eye Clinic Albury Wodonga · Regeneron Pharmaceuticals · NCT06541704 A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS
Phase 2 · Border Medical Oncology Research · Takeda · NCT04419649 Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
Phase 2 · ADARx Clinical Site · ADARx Pharmaceuticals, Inc. · NCT06990269 YN001-004 in Patients With Coronary Atherosclerosis in Australia
Phase 2 · Albury Wodonga Private Hospital · Beijing Inno Medicine Co., Ltd. · NCT06700720 A Study to Learn More About How Safe BAY 3771249 is and How Well it Works in People With Advanced or Metastatic Colorect
Phase 1 · Border Medical oncology - Albury Wodonga Regional Cancer Cen · Bayer · NCT07535112 Working Out M0 Bipolar Androgen Therapy
Phase 2 · The Border Cancer Hospital · Australian and New Zealand Urogenital and Prostate Cancer Tr · NCT06594926

Look up another city

Look up another condition